We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
QURE icon
76
uniQure
QURE
$3.03B
$3.03B $43.63 3.41%
CLDX icon
77
Celldex Therapeutics
CLDX
$2.99B
$2.99B $38.06 1.12%
IRON icon
78
Disc Medicine
IRON
$2.96B
$2.96B $77 2.79%
ATAI icon
79
AtaiBeckley Inc
ATAI
$2.66B
$2.66B $7.18 0%
BEAM icon
80
Beam Therapeutics
BEAM
$2.63B
$2.63B $25.52 3.66%
KOD icon
81
Kodiak Sciences
KOD
$2.6B
$2.6B $41.58 2.16%
TRVI icon
82
Trevi Therapeutics
TRVI
$2.59B
$2.59B $18.25 0.82%
IMNM icon
83
Immunome
IMNM
$2.58B
$2.58B $22.76 1.39%
TARS icon
84
Tarsus Pharmaceuticals
TARS
$2.58B
$2.58B $59.04 0.84%
RARE icon
85
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.45B $24.91 4.34%
NRIX icon
86
Nurix Therapeutics
NRIX
$2.41B
$2.41B $23.21 1.57%
NKTR icon
87
Nektar Therapeutics
NKTR
$2.39B
$2.39B $70.67 1.09%
VCEL icon
88
Vericel Corp
VCEL
$2.35B
$2.35B $45.96 3.47%
VERA icon
89
Vera Therapeutics
VERA
$2.3B
$2.3B $32.10 2.87%
PHVS icon
90
Pharvaris
PHVS
$2.28B
$2.28B $32.62 3.72%
MLYS icon
91
Mineralys Therapeutics
MLYS
$2.25B
$2.25B $25.52 2.56%
PGEN icon
92
Precigen
PGEN
$2.24B
$2.24B $6.27 5.56%
COAG
93
Hemab Therapeutics
COAG
$2.22B
$2.22B $47.55 0.17%
NUVB icon
94
Nuvation Bio
NUVB
$2.2B
$2.2B $6.33 5.52%
KLRA
95
Kailera Therapeutics
KLRA
$2.19B
$2.19B $16.94 0.65%
SION
96
Sionna Therapeutics
SION
$2.13B
$2.13B $47.13 0.75%
VRDN icon
97
Viridian Therapeutics
VRDN
$2.09B
$2.09B $18.92 4.92%
ZLAB icon
98
Zai Lab
ZLAB
$2.06B
$2.06B $18.27 0.33%
HRMY icon
99
Harmony Biosciences
HRMY
$2.04B
$2.04B $35.24 1.73%
BHVN icon
100
Biohaven
BHVN
$2.03B
$2.03B $13.50 2.32%
2 3
4
5 6

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.